Docetaxel Aurobindo

Docetaxel Aurobindo is a chemotherapy medication used to treat various types of cancer. This intravenous drug is manufactured by Eugia Pharma (Malta) Ltd and is part of the EU pharmaceutical market.

Docetaxel is primarily used in the treatment of several types of cancer, including breast, lung, prostate, and stomach cancers. It works by slowing or stopping the growth of cancer cells. The specific uses of docetaxel can vary depending on the type and stage of cancer, as determined by a healthcare provider.

Common effects of docetaxel may include fatigue, nausea, and hair loss. Some patients may also experience changes in blood cell counts, which can lead to increased risk of infection or bleeding. It is important to discuss any persistent or severe side effects with a healthcare professional.

Docetaxel should be handled with care, as it is a potent medication. It is administered intravenously by healthcare professionals in a controlled setting. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Docetaxel may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with docetaxel.